Skip to content

David Katzianer, MD

NPI 1356838460ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Cleveland, OH

Internal Medicine, Advanced Heart Failure and Transplant Cardiology (MD) in Cleveland, Ohio, licensed in OH, with an NPI issued in April 2018. Part D covered 92 prescriptions written in 2024, 37% of them generic. Abbott Laboratories was the largest of 2 companies reporting payments in 2025, $255.57 in all, mostly education.

Overview

NPI1356838460
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedApr 16, 2018
Last updated in NPPESMay 19, 2026
Certified by providerMay 19, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (OH)

Part D prescriptions in 2024

Prescriptions (claims)92 · 133 30-day fills
Patients24
Total drug cost$1,092,468
Generic share37% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$255.57 · 2 payments from 2 companies
  • 2024$136.60 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Abbott Laboratories$238.181
Angiodynamics, Inc.$17.391

What the 2025 payments were for

  • Education$238.18 · 1 payment
  • Food and Beverage$17.39 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Cleveland

All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Ohio →